logo
appgoogle
EquityWireQ2 Earnings: Sun Pharma posts consol net profit of INR 31.18 bln for Jul-Sept
Q2 Earnings

Sun Pharma posts consol net profit of INR 31.18 bln for Jul-Sept

This story was originally published at 16:17 IST on 5 November 2025
Register to read our real-time news.

Informist, Wednesday, Nov. 5, 2025

MUMBAI - Sun Pharma Ltd. reported a consolidated net profit of INR 31.18 billion for the September quarter, against INR 30.40 billion a year ago. Analysts had estimated the net profit at INR 29.44 billion. The company's consolidated revenue for Jul-Sept came in at INR 144.78 billion, against INR 132.91 billion a year ago.

* Sun Pharma Jul-Sept consol net profit INR 31.18 bln
* Analysts saw Sun Pharma Jul-Sept consol net profit at INR 29.44 bln
* Sun Pharma Jul-Sept consol revenue INR 144.78 bln
* Analysts saw Sun Pharma Jul-Sept consol revenue at INR 142.51 bln
* Sun Pharma Jul-Sept consol net profit INR 31.18 bln vs INR 30.40 bln yr ago
* Sun Pharma Jul-Sept consol revenue INR 144.78 bln vs INR 132.91 bln yr ago
* Sun Pharma Apr-Sept consol net profit 53.97 INR bln vs INR 58.76 bln yr ago
* Sun Pharma Apr-Sept consol revenue INR 283.30 bln vs INR 259.44 bln yr ago

More to follow...

To read more please subscribe

Share this Story:

twitterlinkedinwhatsappmaillinkprint

Related Stories

Premium Stories

Subscribe